Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS (Severe Acute Respiratory Syndrome)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT04361461
What this trial is testing

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Who this might be right for
Coronavirus InfectionsSARS-CoV 2SARS (Severe Acute Respiratory Syndrome)+1 more
Apsen Farmaceutica S.A.
Testing effectiveness (Phase 2)WithdrawnNCT05018975
What this trial is testing

Tazemetostat for the Treatment of Moderate to Severe COVID-19 Infection

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeCytokine Release Syndrome
Loma Linda University
Early research (Phase 1)Study completedNCT04532294
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants

Who this might be right for
Covid19
BeiGene 18
Early research (Phase 1)Study completedNCT04461353
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
Pulmoquine Therapeutics, Inc 12
Testing effectiveness (Phase 2)Study completedNCT04701710
What this trial is testing

Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)
Maria de los Angeles Peral de Bruno 300
Testing effectiveness (Phase 2)Ended earlyNCT04409873
What this trial is testing

Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)

Who this might be right for
COVID-19SARS-CoV 2Severe Acute Respiratory Syndrome Coronavirus 2+3 more
University of California, San Francisco 54
Large-scale testing (Phase 3)Enrolling By InvitationNCT05787418
What this trial is testing

HH-120 Nasal Spray for Post-exposure Prevention of SARS-CoV-2

Who this might be right for
COVID-19
Huahui Health 1,200
Not applicableActive Not RecruitingNCT04880174
What this trial is testing

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel Following mRNA COVID-19 Vaccination

Who this might be right for
SARS-CoV Infection
Universitair Ziekenhuis Brussel 500
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Testing effectiveness (Phase 2)Study completedNCT04375397
What this trial is testing

Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury

Who this might be right for
CoronaVirus Induced Disease-2019 (COVID-19)
AbbVie 46
Not applicableStudy completedNCT04374617
What this trial is testing

Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19

Who this might be right for
COVID-19Critical IllnessVenous Thromboembolism+7 more
Hospital Universitari Vall d'Hebron Research Institute 230
Not applicableStudy completedNCT05894525
What this trial is testing

Post-Marketing Safety Study in Japan in Participants With High Risk of Severe Exacerbation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA-1273 COVID-19 Vaccine

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 8,844
Post-approval studies (Phase 4)Study completedNCT04969250
What this trial is testing

Vaccination for Recovered Inpatients With COVID-19 (VATICO)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 66
Testing effectiveness (Phase 2)Ended earlyNCT04969991
What this trial is testing

Study of Varespladib in Patients Hospitalized With Severe COVID-19

Who this might be right for
Coronavirus Disease 2019Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
Ophirex, Inc. 18
Not applicableStudy completedNCT04542954
What this trial is testing

Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East

Who this might be right for
Covid19Kidney Transplant InfectionRisk Factor, Cardiovascular+3 more
Hamid Al-Essa Organ Transplant Center 104
Testing effectiveness (Phase 2)UnknownNCT04397497
What this trial is testing

Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)

Who this might be right for
Covid-19Acute Respiratory FailureARDS, Human+2 more
Ospedale San Raffaele 50
Large-scale testing (Phase 3)Ended earlyNCT04341727
What this trial is testing

Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection

Who this might be right for
Coronavirus Infection
Washington University School of Medicine 30
Early research (Phase 1)Ended earlyNCT04866069
What this trial is testing

Study of a Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Adjuvanted Inactivated Vaccine in Healthy Adults

Who this might be right for
Covid19
Osman ERGANIS, PhD, Prof 50
Large-scale testing (Phase 3)Study completedNCT04590586
What this trial is testing

Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

Who this might be right for
COVID-19
Amgen 515
Large-scale testing (Phase 3)Ended earlyNCT04369469
What this trial is testing

Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia

Who this might be right for
COVID-19 Severe PneumoniaAcute Lung InjuryAcute Respiratory Distress Syndrome+1 more
Alexion Pharmaceuticals, Inc. 202
Next Page